Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AHR | P35869 | 2/20 | 0.34 |
| ▸ | ALK | Q9UM73 | 6/20 | 0.34 |
| ▸ | MEN1 | O00255 | 3/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.33 |
| ▸ | MAPT | P10636 | 2/20 | 0.33 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.33 |
| ▸ | HPGD | P15428 | 2/20 | 0.33 |
| ▸ | PGR | P06401 | 1/20 | 0.33 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.32 |
| ▸ | PDK2 | Q15119 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 2/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | HTR2B | P41595 | 1/20 | 0.30 |
| ▸ | NPC1 | O15118 | 1/20 | 0.30 |
| ▸ | RAB9A | P51151 | 1/20 | 0.30 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL22680310 | 0.97 | ALK (0.32) | AHRALKMEN1KMT2AMAPT | |
| SCHEMBL26687784 | 0.96 | PGR (0.35) | AHRALKMEN1KMT2AMAPT | |
| SCHEMBL21094724 | 0.95 | ALK (0.36) | ALKPGRMAOAALOX5PDK2 | |
| SCHEMBL26687737 | 0.95 | MEN1 (0.34) | AHRALKMEN1KMT2AMAPT | |
| SCHEMBL20871765 | 0.94 | ALK (0.35) | ALKPGRALOX5PDK2 | |
| SCHEMBL24754247 | 0.93 | ALK (0.34) | ALKPDK2 | |
| SCHEMBL19537870 | 0.93 | ALK (0.34) | ALKPDK2 | |
| SCHEMBL21094873 | 0.93 | ALK (0.36) | AHRALKMEN1KMT2AMAPT | |
| SCHEMBL20871741 | 0.93 | ALK (0.35) | ALKPGRALOX5PDK2 | |
| SCHEMBL22679995 | 0.93 | ALK (0.33) | ALK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-11711973-B2 | Organic electronic device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-07-25 | — | — | US | disclosed |
| US-20230140925-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230140925-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | DUK SAN NEOLUX CO., LTD. (KR) | 2023-05-11 | — | — | US | disclosed |
| US-20230111469-A1 | Organic Electronic Device | DUK SAN NEOLUX CO., LTD. (KR) | 2023-04-13 | — | — | US | disclosed |
| US-20190185460-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | SAMSUNG DISPLAY CO., LTD. (KR) | 2019-06-20 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230140925-A1 | COMPOUND FOR ORGANIC ELECTRICAL ELEMENT, ORGANIC ELECTRICAL ELEMENT USING SAME, AND ELECTRONIC DEVICE COMPRISING SAME | OR51E2, OR10J3, ORAI2 | AHR 1522/4885ALK 2690/4885MEN1 1123/4885 |
| US-20190185460-A1 | AMINE-BASED COMPOUND AND ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE SAME | AOC2, TYR, MAOB | AHR 115/4885ALK 103/4885MEN1 190/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.